TY - JOUR
T1 - Peroxisome proliferator-activated receptor-γ pro12ala polymorphism and risk of osteopenia in β-thalassemia major patients
AU - Sahmani, Mehdi
AU - Gholami, Abdollah
AU - Azarkeivan, Azita
AU - Darabi, Masoud
AU - Ahmadi, Mohammad Hossein
AU - Sabet, Majid Sirati
AU - Najafipour, Reza
N1 - Funding Information:
Declaration of Interest: This study was partially supported by grants from the Cellular and Molecular Research Centre Qazvin University of Medical Sciences, Qazvin, Iran. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.
PY - 2013
Y1 - 2013
N2 - Genetic factors have an important role in the incidence of osteopenia in thalassemia patients. The purpose of this study was to investigate the effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ (PPARγ) gene on bone mineral density (BMD) and subsequently, the rate of osteopenia in β-thalassemia major (β-TM) patients. Blood samples were obtained from 156 β-TM patients referred to the Tehran and Qazvin Thalassemia Clinics. Samples were analyzed for polymorphisms of the PPARγ gene using polymerase chain reaction-restriction fragment length polymorphism (RFLP)-based methods. Multivariate analysis was used to investigate the relationship between the risk of osteopenia and the PPARγ gene polymorphism. Correlation analysis showed that there was a significant association between homozygous wild-type genotypes with susceptibility to osteopenia in β-TM patients (p = 0.024). Logistic regression analysis showed that the risk of osteopenia was significantly (p <0.05) higher in the homozygous wild-type genotype than carriers of the rare alleles. Furthermore, the associations were strengthened in men with a homozygous wild-type genotype after adjustment for age and body mass index (BMI) (p <0.05). This study suggests that the Pro12Ala polymorphism of the PPARγ gene might be an independent factor in BMD level and osteopenia in thalassemia patients.
AB - Genetic factors have an important role in the incidence of osteopenia in thalassemia patients. The purpose of this study was to investigate the effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ (PPARγ) gene on bone mineral density (BMD) and subsequently, the rate of osteopenia in β-thalassemia major (β-TM) patients. Blood samples were obtained from 156 β-TM patients referred to the Tehran and Qazvin Thalassemia Clinics. Samples were analyzed for polymorphisms of the PPARγ gene using polymerase chain reaction-restriction fragment length polymorphism (RFLP)-based methods. Multivariate analysis was used to investigate the relationship between the risk of osteopenia and the PPARγ gene polymorphism. Correlation analysis showed that there was a significant association between homozygous wild-type genotypes with susceptibility to osteopenia in β-TM patients (p = 0.024). Logistic regression analysis showed that the risk of osteopenia was significantly (p <0.05) higher in the homozygous wild-type genotype than carriers of the rare alleles. Furthermore, the associations were strengthened in men with a homozygous wild-type genotype after adjustment for age and body mass index (BMI) (p <0.05). This study suggests that the Pro12Ala polymorphism of the PPARγ gene might be an independent factor in BMD level and osteopenia in thalassemia patients.
UR - http://www.scopus.com/inward/record.url?scp=84887260889&partnerID=8YFLogxK
U2 - 10.3109/03630269.2013.814035
DO - 10.3109/03630269.2013.814035
M3 - Journal articles
C2 - 23909657
AN - SCOPUS:84887260889
SN - 0363-0269
VL - 37
SP - 564
EP - 573
JO - Hemoglobin
JF - Hemoglobin
IS - 6
ER -